[HTML][HTML] Polypill strategy in secondary cardiovascular prevention
JM Castellano, SJ Pocock, DL Bhatt… - … England Journal of …, 2022 - Mass Medical Soc
Background A polypill that includes key medications associated with improved outcomes
(aspirin, angiotensin-converting–enzyme [ACE] inhibitor, and statin) has been proposed as …
(aspirin, angiotensin-converting–enzyme [ACE] inhibitor, and statin) has been proposed as …
Polypill Strategy in Secondary Cardiovascular Prevention
JM Castellano, SJ Pocock, DL Bhatt… - THE NEW ENGLAND …, 2022 - air.unimi.it
BACKGROUND A polypill that includes key medications associated with improved outcomes
(aspirin, angiotensin-converting-enzyme [ACE] inhibitor, and statin) has been proposed as a …
(aspirin, angiotensin-converting-enzyme [ACE] inhibitor, and statin) has been proposed as a …
Polypill Strategy in Secondary Cardiovascular Prevention
JM Castellano, SJ Pocock, DL Bhatt… - New England Journal …, 2022 - cir.nii.ac.jp
Polypill Strategy in Secondary Cardiovascular Prevention | CiNii Research CiNii 国立情報学
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …
Polypill strategy in secondary cardiovascular prevention
JM Castellano, SJ Pocock, DL Bhatt… - New England Journal …, 2022 - ppm.edu.pl
/methods Abstract in original language Background: A polypill that includes key medications
associated with improved outcomes (aspirin, angiotensin-converting-enzyme [ACE] inhibitor …
associated with improved outcomes (aspirin, angiotensin-converting-enzyme [ACE] inhibitor …
original: Polypill
J Castellano, S Pocock, V Fuster - New England Journal of Medicine, 2022 - siicsalud.com
El artículo original fue seleccionado de la base de datos SIIC Data Bases por la compañía
patrocinante. Los datos y la información publicados pueden ser preliminares y estar sujetos …
patrocinante. Los datos y la información publicados pueden ser preliminares y estar sujetos …
Polypill Strategy in Secondary Cardiovascular Prevention
JM Castellano, A Fernandez-Ortiz, HJ Bueno Zamora… - 2022 - docta.ucm.es
Polypill Strategy in Secondary Cardiovascular Prevention Repository logo Español English
Log In My UCM account Password login Email address Password Log in Repository logo …
Log In My UCM account Password login Email address Password Log in Repository logo …
[引用][C] Polypill Strategy in Secondary Cardiovascular Prevention
JM Castellano, SJ Pocock… - The New England …, 2022 - produccioncientifica.ucm.es
original: Polypill
J Castellano, S Pocock, V Fuster - New England Journal of Medicine, 2022 - siicsalud.com
El artículo original fue seleccionado de la base de datos SIIC Data Bases por la compañía
patrocinante. Los datos y la información publicados pueden ser preliminares y estar sujetos …
patrocinante. Los datos y la información publicados pueden ser preliminares y estar sujetos …
Polypill Strategy in Secondary Cardiovascular Prevention.
JM Castellano, SJ Pocock, DL Bhatt… - The New England …, 2022 - europepmc.org
Background A polypill that includes key medications associated with improved outcomes
(aspirin, angiotensin-converting-enzyme [ACE] inhibitor, and statin) has been proposed as a …
(aspirin, angiotensin-converting-enzyme [ACE] inhibitor, and statin) has been proposed as a …
[PDF][PDF] Polypill Strategy in Secondary Cardiovascular Prevention
JM Castellano, SJ Pocock, DL Bhatt, AJ Quesada… - 2022 - newswise.com
Background A polypill that includes key medications associated with improved outcomes
(aspirin, angiotensin-converting–enzyme [ACE] inhibitor, and statin) has been proposed as …
(aspirin, angiotensin-converting–enzyme [ACE] inhibitor, and statin) has been proposed as …